期刊文献+

Smartphone-Imaged HIV-1 Reverse-Transcription Loop-Mediated Isothermal Ampliflcation(RT-LAMP) on a Chip from Whole Blood 被引量:9

Smartphone-Imaged HIV-1 Reverse-Transcription Loop-Mediated Isothermal Ampliflcation(RT-LAMP) on a Chip from Whole Blood
下载PDF
导出
摘要 Viral load measurements are an essential tool for the long-term clinical care of human immunodeficiency virus (HIV)-positive individuals. The gold standards in viral load instrumentation, however, are still too limited by their size, cost, and sophisticated operation for these measurements to be ubiquitous in remote settings with poor healthcare infrastructure, including parts of the world that are disproportionately affected by HIV infection. The challenge of developing a point-of-care platform capable of making viral load more accessible has been frequently approached but no solution has yet emerged that meets the practical requirements of low cost, portability, and ease-of-use. In this paper, we perform reverse-transcription loop-mediated isothermal amplification (RT-LAMP) on minimally processed HIV-spiked whole blood samples with a microfluidic and silicon microchip platform, and perform fluorescence measurements with a consumer smartphone. Our integrated assay shows amplification from as few as three viruses in a - 60 nL RT- LAMP droplet, corresponding to a whole blood concentration of 670 viruses per μL of whole blood. The technology contains greater power in a digital RT-LAMP approach that could be scaled up for the determination of viral load from a finger prick of blood in the clinical care of HIV-positive individuals. We demonstrate that all aspects of this viral load approach, from a drop of blood to imaging the RT-LAMP reaction, are compatible with lab-on-a-chip components and mobile instrumentation. Viral load measurements are an essential tool for the long-term clinical care of hum an immunodeficiency virus(HIV)-positive individuals. The gol d standards in viral load instrumentation, however, are still too limited by their size, cost, and sophisticated operation for these measurements to be ubiquitous in remote settings with poor healthcare infrastructure, including parts of the world that are disproportionately affected by HIV infection. The challenge of developing a point-of-care platform capable of making viral load more accessible has been frequently approached but no solution has yet emerged that meets the practical requirements of low cost, portability, and ease-of-use. In this paper, we perform reverse-transcription loop-mediated isothermal amplification(RT-LAMP) on minimally processed HIV-spiked whole blood samples with a microfluidic and silicon microchip platform, and perform fluorescence measurements with a consumer smartphone. Our integrated assay shows amplification from as few as three viruses in a ~ 60 nL RTLAMP droplet, corresponding to a whole blood concentration of 670 viruses per μL of whole blood. The technology contains greater power in a digital RT-LAMP approach that could be scaled up for the determination of viral load from a flnger prick of blood in the clinical care of HIV-positive individuals. We demonstrate that all aspects of this viral load approach, from a drop of blood to imaging the RT-LAMP reaction, are compatible with lab-on-a-chip components and mobile instrumentation.
出处 《Engineering》 SCIE EI 2015年第3期324-335,共12页 工程(英文)
基金 supported by funding from the National Institutes of Health (NIH) Exploratory/Developmental Grant (R21) (AI106024) supported by a Ruth L.Kirschstein National Research Service Award for Individual Pred octoral MD/PhD and Other Dual Doctoral Degree Fellows (F30) (AI109825)
关键词 human immunodeficiency virus (HIV) viral load loop-mediated isothermal amplification SMARTPHONE POINT-OF-CARE HIV-1 LAMP 智能手机 硅芯片 逆转录 全血 艾滋病毒感染 等温
  • 相关文献

参考文献40

  • 1World Health Organization. HIV/AIDS fact sheet. 201412015-08-01J.http:// www.who.int/mediacentre/factsheets/fs360/en/#.
  • 2World Health Organization, UNICEF, UNAIDS. Global Update on HIV Treatment 2013: Results, Impact and Opportunities. Geneva: WHO Press, 2013.
  • 3J. A. Aberg, J. E. Gallant, K. G. Ghanem, P. Emmanuel, B. S. Zingman, M. A. Horberg; Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin. Infect. Dis., 2014, 58(1): el-e34.
  • 4Alere. Alere PimaTM CD4. 201212015-05-05J.http://alerehiv.com/hiv-moni- toring/alere-pima-cd4/.
  • 5Daktari Diagnostics. Products. 201312015-05-05J.http://www.daktaridx. corn/products/.
  • 6G. L. Damhorst, N. N. Watkins, R. Bashir. Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings. IEEE Trans. Biomed. Eng., 2013, 60(3): 715-726.
  • 7C. F. Rowley. Developments in CD4 and viral load monitoring in resource- limited settings. Clin. Infect. Dis., 2014, 58(3): 407-412.
  • 8US Food and Drug Administration. Complete list of donor screening as- says for infectious agents and HIV diagnostic assays. 2013.
  • 9US Food and Drug Administration. Vaccines, blood & biologics: HIV-1. 201012014-03-17J.http://www.fda.gov/BiologicsBloodVaccines/Blood- BloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDo- norScreening/InfectiousDisease/ucm126582.htm.
  • 10T. Peterson, M. Stuart. HIV Testing Overview. 201112014-03-17J.http:// emedicine.medscape.com/ar ticle/1983649-overview.

同被引文献50

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部